產(chǎn)品詳情
簡單介紹：
Anti-EGR2抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗抗體。Anti-EGR2抗體用于**組化實(shí)驗,WB實(shí)驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-EGR2
Cat. Number:
Anti-EGR2抗體KL-8368R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Egr proteins function in transcription regulatory activities surrounding cellular growth, differentiation and function. The deduced amino acid sequences of human Egr-2 and mouse Egr-1 are 92% identical in the zinc fingerAnti-EGR2抗體 region but show no homology elsewhere. Egr-2 is a sequence-specific DNA-binding transcription factor that binds two specific DNA sites located in the promoter region of HoxA4 and localizes to the nucleus. Defects in the Egr-2 protein are a cause of congenital hypomyelination neuropathy (CHN). CHN is characterized clinically by early onset of hypotonia, areflexia, distal muscle weakness and very slow nerve conduction velocities. Mutations in the gene that encodes Egr-2 (EGR2) also cause Dejerine-Sottas syndrome (DSS), which is also known as Dejerine-Sottas neuropathy (DSN) or hereditary motor and sensory neuropathy III (HMSN3). DSS patients exhibit severe early onset motor and sensory neuropathy with very slow nerve conduction velocities and elevated cerebrospinal fluid protein concentrations.
Also known as:
CMT1D; CMT4E; DKFZp686J1957;Anti-EGR2抗體 Early growth response 2; Early growth response protein 2; EGR-2; egr2; EGR2_HUMAN; FLJ14547; KROX 20 Drosophila homolog; Krox 20 homolog Drosophila; KROX20; Krox20 protein; Zinc finger protein Krox-20; AT591.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human EGR2.
●
Predicted Molecular Weight:Anti-EGR2抗體 50kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications. Anti-EGR2抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-EGR2抗體
Optimal working dilutions must be determined by the end user.
kl080Hu01 白介素8(IL8)多克隆抗體 Polyclonal Antibody to Interleukin 8 (IL8)
kl080Gu01 白介素8(IL8)多克隆抗體 Polyclonal Antibody to Interleukin 8 (IL8)
kl080Rb52 白介素8(IL8)多克隆抗體 Polyclonal Antibody to Interleukin 8 (IL8)
kl080Ca01 白介素8(IL8)多克隆抗體 Polyclonal Antibody to Interleukin 8 (IL8)
kl080Po01 白介素8(IL8)多克隆抗體 Polyclonal Antibody to Interleukin 8 (IL8)
kl080Bo01 白介素8(IL8)多克隆抗體 Polyclonal Antibody to Interleukin 8 (IL8)
kl080Cp01 白介素8(IL8)多克隆抗體 Polyclonal Antibody to Interleukin 8 (IL8)
kl080Eq01 白介素8(IL8)多克隆抗體 Polyclonal Antibody to Interleukin 8 (IL8)
kl080Ga01 白介素8(IL8)多克隆抗體 Polyclonal Antibody to Interleukin 8 (IL8)
kl093Hu01 白介素8抑制因子(IL8INH)多克隆抗體 Polyclonal Antibody to Interleukin 8 Inhibitor (IL8INH)
kl448Hu01 胰島素(INS)多克隆抗體 Polyclonal Antibody to Insulin (INS)
kl448Mu01 胰島素(INS)多克隆抗體 Polyclonal Antibody to Insulin (INS)
kl448Ra01 胰島素(INS)多克隆抗體 Polyclonal Antibody to Insulin (INS)
kl448Rb51 胰島素(INS)多克隆抗體 Polyclonal Antibody to Insulin (INS)
kl448Si01 胰島素(INS)多克隆抗體 Polyclonal Antibody to Insulin (INS)
kl448Ca01 胰島素(INS)多克隆抗體 Polyclonal Antibody to Insulin (INS)
kl448Po01 胰島素(INS)多克隆抗體 Polyclonal Antibody to Insulin (INS)
kl448Bo01 胰島素(INS)多克隆抗體 Polyclonal Antibody to Insulin (INS)
kl967Hu01 激肽釋放酶1(KLK1)多克隆抗體 Polyclonal Antibody to Kallikrein 1 (KLK1)
